2025-04-25 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Review

**0. Executive Summary:**

Colgate-Palmolive Co (CL), a leading consumer goods company specializing in oral hygiene and personal care products, has underperformed the S&P 500 (VOO) significantly over the analyzed period. While showing consistent revenue and profitability, its performance is marked by lower growth and higher risk compared to the broader market.  Further analysis reveals potential undervaluation, but necessitates a cautious approach due to market volatility and negative projected short-term returns.

**1. Performance Comparison:**

Colgate-Palmolive's cumulative return (37.81%) significantly lags behind the S&P 500's (82.57%). The current deviation is -44.8%, placing it in the 29.4th percentile of historical performance relative to the S&P 500.  This suggests underperformance compared to the benchmark, although historical context is crucial.

Colgate-Palmolive Co is a major consumer staples company manufacturing and selling household, personal care, and pet products globally.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 16.0% | 4.2% | -16.0% | 0.1 | 51.2 |
| 2016-2018  | -9.0% | 65.3% | -30.0% | 0.1 | 41.4 |
| 2017-2019  | 10.0% | 65.3% | -24.0% | -0.3 | 49.1 |
| 2018-2020  | 22.0% | 65.3% | -8.0% | 0.3 | 62.4 |
| 2019-2021  | 34.0% | 58.5% | -26.0% | 0.8 | 63.7 |
| 2020-2022  | 11.0% | 68.9% | 2.0% | 0.7 | 60.3 |
| 2021-2023  | 8.0% | 68.9% | -13.0% | 0.6 | 62.5 |
| 2022-2024  | 16.0% | 68.9% | -5.0% | 0.5 | 72.9 |
| 2023-2025  | 15.0% | 62.4% | -6.0% | 0.2 | 75.2 |

The Alpha values fluctuate, indicating inconsistent outperformance relative to the market. The Beta consistently remains below 1, suggesting lower volatility than the market.  However, the negative Alphas in some periods highlight underperformance.


**2. Recent Price Movements:**

* **Closing Price:** $92.70
* **Previous Close:** $93.89
* **Change:** -$1.27 (Down 1.35%)
* **5-Day Moving Average:** $94.52
* **20-Day Moving Average:** $92.81
* **60-Day Moving Average:** $90.45

The price is slightly below the 20-day moving average, suggesting a potential short-term bearish trend. However, it's above the 60-day moving average, indicating longer-term support. The recent price drop is notable.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4053 (Medium Risk)
* **RSI:** 43.92 (Approaching oversold territory, but not yet definitively so)
* **PPO:** 0.0968 (Slightly positive, suggesting weak bullish momentum)
* **20-Day Relative Strength Change:** -9.1% (Short-term bearish trend)
* **Expected Return:** -88.2% (This extremely negative figure needs clarification.  It likely represents a short-term prediction and is not necessarily reflective of long-term potential.  The context of this figure is crucial for proper interpretation).


The recent price drop (-1.27) reflects a short-term market adjustment. The negative expected return highlights significant short-term risk.


**4. Recent Earnings Analysis:**

| Date       | EPS | Revenue       |
|------------|-----|---------------|
| 2024-10-25 | $0.9 | $5.03 Billion |
| 2024-07-26 | $0.89| $5.06 Billion |
| 2024-04-26 | $0.83| $5.07 Billion |
| 2023-10-27 | $0.86| $4.92 Billion |
| 2023-10-25 | $0.86| $4.92 Billion | *(Duplicate entry, likely a typo)*

Earnings are relatively stable, showing slight growth in revenue and EPS.  The duplicate entry needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue  | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $4.95B  | 60.30%       |
| 2024-09-30 | $5.03B  | 61.08%       |
| 2024-06-30 | $5.06B  | 60.62%       |
| 2024-03-31 | $5.07B  | 60.00%       |
| 2023-12-31 | $4.95B  | 59.60%       |

Revenue is relatively stable, with consistent high profit margins.

**Capital and Profitability:**

| Quarter | Equity (B) | ROE (%)  |
|---------|------------|----------|
| 2024-12-31 | $0.21     | 348.58%  |
| 2024-09-30 | $0.43     | 169.43%  |
| 2024-06-30 | $0.12     | 594.31%  |
| 2024-03-31 | $0.23     | 296.96%  |
| 2023-12-31 | $0.61     | 117.90%  |

ROE is highly volatile, suggesting potential accounting adjustments or unusual factors impacting the equity values need further investigation.  The extremely high ROE values in some quarters require careful scrutiny and clarification.


**6. Overall Analysis:**

Colgate-Palmolive demonstrates consistent revenue and profitability, although its growth has lagged the S&P 500 significantly. The company's relatively low beta indicates lower volatility than the market, but the fluctuating Alpha values signal inconsistent outperformance.  Recent price movements show a slight bearish trend, while technical indicators suggest a moderately risky position. The highly volatile ROE figures require detailed investigation. The extremely negative projected return needs clarification and should not be taken as a definitive long-term forecast.  For long-term investors, the potential undervaluation relative to the market, coupled with the consistent revenue stream and high margins, might warrant consideration.  However, a thorough due diligence investigation is essential, focusing on the volatility of equity and ROE data, and a clear understanding of the -88.2% projected return.  Additional information is necessary for a complete and accurate assessment.
